Bristol Myers Squibb reported $9.25B in Gross Profit on Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 6505M 1225M
Amgen AMGN:US $ 4889M 478M
Astrazeneca AZN:US 6.03B 627M
AstraZeneca AZN:LN 6.03B 627M
Biogen BIIB:US $ 2267.1M 48.2M
Bristol Myers Squibb BMY:US $ 9252M 682M
Catalent CTLT:US $ 439.3M 73.7M
Coherus Biosciences CHRS:US $ 70.95M 4.58M
Drreddys Laboratories RDY:US $ 25699M 324M
Eli Lilly And LLY:US $ 4786.9M 140.1M
Endo International Ordinary Shares ENDP:US $ 400.4M 27.52M
Gilead Sciences GILD:US $ 4827M 235M
GlaxoSmithKline GSK:LN 5.57B 566M
Gw Pharmaceuticals GWPH:US $ 140.66M 2.86M
Horizon Pharma HZNP:US $ 631.55M 389.52M
Intercept Pharmaceuticals ICPT:US $ 95.96M 15.11M
JAZZ PHA JAZZ:US $ 632.62M 65.22M
Johnson & Johnson JNJ:US $ 16088M 343M
Lannett LCI:US $ 22.66M 3.8M
Medtronic MDT:US $ 5389M 179M
Merk MRK:US $ 8718M 93M
Novartis NOVN:VX 9.54B 679M
Perrigo Ordinary Shares PRGO:US $ 349M 19.4M
Pfizer PFE:US $ 11985M 1575M
Phibro Animal Health PAHC:US $ 69.83M 0.66M
Prestige Brands PBH:US $ 159.01M 21.96M
Regeneron Pharmaceuticals REGN:US $ 4444.8M 2224.1M
Revance Therapeutics RVNC:US $ 13.38M 4.3M
Teva Pharmaceutical Industries TEVA:US $ 1923M 4M
United Therapeutics UTHR:US $ 409.3M 53.2M
Zoetis ZTS:US $ 1384M 56M